TP53 and cancer: In the HBV-HCC continuum, upregulated miRNA often reduce tumor suppressor expression in the four key HCC cancer pathways, namely, the P13K/MAPK, WNT/β-Catenin, TP53 and JAK/STAT pathways (125).